36E79725R0019_1.docx

This is a presolicitation notice for RFP 36E79725R0019 for Bevacizumab Injections to be issued by the VA National Acquisition Center. The unrestricted procurement will result in one contract award with a one-year base period plus four one-year options to supply the Department of Veterans Affairs (including CMOPs and SVH), Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center.

The solicitation will be issued around February 18, 2025, with responses due March 4, 2025 at 2:30 PM Central Time. The contractor must provide Bevacizumab injections in either 4mL or 16mL vial sizes, with estimated annual requirements ranging from approximately 23,000-23,500 vials for 4mL size and 4,800-13,900 vials for 16mL size. Five product options are specified: Avastin (Bevacizumab), Mvasi (Bevacizumab-awwb), Alymsys (Bevacizumab-maly), Vegzelma (Bevacizumab-adcd), or Zirabev (Bevacizumab-bvzr). Products will be distributed through VA and DOD pharmaceutical prime vendor programs. The NAICS code is 325412 and the point of contact is Matthew Poulin at the VA National Acquisition Center in Hines, IL.